title: Commment on the review entitled "A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer" by Chiva LM and Gonzalez-Martin A.
abstract: •We raised some methodological concerns and made some comments on the systematic review by Chiva and colleague.•To state that Cytoreduction & HIPEC is not beneficial in front line and platinum sensitive recurrence is highly disputable.•Anyway, the combined treatment should be offered in the context of clinical trial; randomized data are urgently needed.
authors.affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of surgery, Colorectal Cancer Unit, Peritoneal Surface Malignancies Program, Via Venezian, 1, Milano, MI Cap 20133, Italy.
authors.forename: Marcello
authors.initials: M
authors.lastname: Deraco
authors.affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of surgery, Colorectal Cancer Unit, Peritoneal Surface Malignancies Program, Via Venezian, 1, Milano, MI Cap 20133, Italy.
authors.forename: Shigeki
authors.initials: S
authors.lastname: Kusamura
authors.affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of surgery, Colorectal Cancer Unit, Peritoneal Surface Malignancies Program, Via Venezian, 1, Milano, MI Cap 20133, Italy.
authors.forename: Dario
authors.initials: D
authors.lastname: Baratti